ONTOLOGY REPORT - ANNOTATIONS
| Term: | bezafibrate |
|
| Accession: | CHEBI:47612
|
browse the term
|
| Definition: | A monocarboxylic acid amide that has formula C19H20ClNO4. |
| Synonyms: | exact_synonym: | 2-{4-[2-(4-chlorobenzamido)ethyl]phenoxy}-2-methylpropanoic acid |
| | related_synonym: | 2-[P-[2-P-CHLOROBENZAMIDO)ETHYL]PHENOXY]-2-METHYLPROPIONIC ACID; Befizal; Bezalip; Bezatol SR (TN); C19H20ClNO4; CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(O)=O; Cedur; InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24); InChIKey=IIBYAHWJQTYFKB-UHFFFAOYSA-N; bezafibrato; bezafibratum |
| | alt_id: | CHEBI:31284; CHEBI:47611 |
| | xref_casrn: | 41859-67-0 |
| | xref: | ChEMBL:157488 "ChEMBL COMPOUND"; ChemIDplus:41859-67-0 "CAS Registry Number"; DrugBank:DB01393 "DrugBank"; KEGG DRUG:41859-67-0 "CAS Registry Number"; KEGG DRUG:D01366 "KEGG DRUG" |
| | xref_mesh: | MESH:D001629 |
| | xref: | PDBeChem:PEM "PDBeChem"; Patent:DE2149070 "Patent"; Patent:US3781328 "Patent"; Wikipedia:Bezafibrate "Wikipedia" |
|
|
bezafibrate
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
affects localization |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
increases expression |
ISO |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
affects localization |
ISO |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
multiple interactions |
ISO |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
increases expression |
ISO |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
increases expression |
ISO |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
increases expression |
EXP |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
increases expression |
ISO |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
increases expression |
ISO |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
multiple interactions |
ISO |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
increases expression |
ISO |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
affects localization |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases transport |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcd3 |
ATP-binding cassette, subfamily D (ALD), member 3 |
|
increases expression |
ISO |
2 |
218,396,071 |
218,432,172 |
RGD:6480464 |
CTD |
| G |
Abcd3 |
ATP-binding cassette, subfamily D (ALD), member 3 |
|
increases expression |
ISO |
2 |
218,396,071 |
218,432,172 |
RGD:6480464 |
CTD |
| G |
Abcg5 |
ATP-binding cassette, subfamily G (WHITE), member 5 |
|
increases expression |
ISO |
6 |
8,027,647 |
8,064,425 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
multiple interactions |
ISO |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
increases expression |
ISO |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
decreases expression |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
increases expression |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
multiple interactions |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
increases expression |
ISO |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
increases expression |
ISO |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
decreases expression |
ISO |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
increases expression |
ISO |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
multiple interactions |
ISO |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
multiple interactions |
ISO |
9 |
65,613,130 |
65,651,775 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
increases expression |
ISO |
9 |
65,613,130 |
65,651,775 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
multiple interactions |
ISO |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
increases expression |
ISO |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
multiple interactions |
ISO |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases expression |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases expression |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
affects response to substance |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
affects response to substance |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases activity |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases expression |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases expression |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases expression |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
multiple interactions |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
multiple interactions |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
multiple interactions |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases expression |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
multiple interactions |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases activity |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases activity |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
multiple interactions |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases activity |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
multiple interactions |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
EXP |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
multiple interactions |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
increases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
increases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
increases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
increases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
multiple interactions |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
multiple interactions |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
increases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
increases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
increases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
increases expression |
ISO |
X |
36,168,547 |
36,232,162 |
RGD:6480464 |
CTD |
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
increases expression |
ISO |
1 |
261,554,383 |
261,599,373 |
RGD:6480464 |
CTD |
| G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
|
affects expression |
EXP |
3 |
146,013,995 |
146,057,119 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases secretion |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipor1 |
adiponectin receptor 1 |
|
increases expression |
ISO |
13 |
47,358,625 |
47,379,565 |
RGD:6480464 |
CTD |
| G |
Adipor2 |
adiponectin receptor 2 |
|
increases expression |
ISO |
4 |
155,664,035 |
155,677,627 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
increases expression |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
|
increases expression |
ISO |
8 |
75,692,099 |
75,771,159 |
RGD:6480464 |
CTD |
| G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
|
affects response to substance |
ISO |
10 |
47,400,518 |
47,421,064 |
RGD:6480464 |
CTD |
| G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
|
increases activity |
ISO |
10 |
47,400,518 |
47,421,064 |
RGD:6480464 |
CTD |
| G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
|
increases expression |
ISO |
10 |
47,400,518 |
47,421,064 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
decreases activity |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases expression |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
increases expression |
ISO |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases expression |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa2 |
apolipoprotein A-II |
|
increases expression |
ISO |
13 |
87,114,734 |
87,116,372 |
RGD:6480464 |
CTD |
| G |
Apoa2 |
apolipoprotein A-II |
|
increases expression |
ISO |
13 |
87,114,734 |
87,116,372 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases expression |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases expression |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases expression |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases expression |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases expression |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases secretion |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases expression |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases expression |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases expression |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apoc2 |
apolipoprotein C-II |
|
decreases expression |
ISO |
1 |
78,979,034 |
78,984,002 |
RGD:6480464 |
CTD |
| G |
Apoc2 |
apolipoprotein C-II |
|
multiple interactions |
ISO |
1 |
78,979,034 |
78,984,002 |
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
multiple interactions |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
multiple interactions |
EXP |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
decreases expression |
EXP |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
increases expression |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
|
multiple interactions |
ISO |
1 |
171,062,181 |
171,162,426 |
RGD:6480464 |
CTD |
| G |
Arpp21 |
cAMP-regulated phosphoprotein 21 |
|
increases expression |
ISO |
8 |
116,674,803 |
116,794,799 |
RGD:6480464 |
CTD |
| G |
Ascl2 |
achaete-scute complex homolog 2 (Drosophila) |
|
decreases expression |
ISO |
1 |
203,242,130 |
203,244,480 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
increases expression |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
increases expression |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Btbd9 |
BTB (POZ) domain containing 9 |
|
increases expression |
ISO |
20 |
8,746,092 |
8,839,817 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
EXP |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd40lg |
CD40 ligand |
|
multiple interactions |
ISO |
X |
141,925,019 |
141,937,183 |
RGD:6480464 |
CTD |
| G |
Cd40lg |
CD40 ligand |
|
decreases activity |
ISO |
X |
141,925,019 |
141,937,183 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Chmp4b |
charged multivesicular body protein 4B |
|
increases expression |
ISO |
3 |
145,138,905 |
145,176,471 |
RGD:6480464 |
CTD |
| G |
Chmp4bl1 |
chromatin modifying protein 4B-like 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Clock |
clock circadian regulator |
|
multiple interactions |
ISO |
14 |
34,218,472 |
34,258,054 |
RGD:6480464 |
CTD |
| G |
Clps |
colipase, pancreatic |
|
increases expression |
ISO |
20 |
6,802,428 |
6,804,608 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
decreases expression |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
multiple interactions |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
multiple interactions |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
EXP |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
increases expression |
ISO |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
multiple interactions |
ISO |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
increases expression |
EXP |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
increases expression |
ISO |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Cpt2 |
carnitine palmitoyltransferase 2 |
|
increases expression |
EXP |
5 |
129,007,685 |
129,025,501 |
RGD:6480464 |
CTD |
| G |
Cpt2 |
carnitine palmitoyltransferase 2 |
|
increases activity |
ISO |
5 |
129,007,685 |
129,025,501 |
RGD:6480464 |
CTD |
| G |
Cpt2 |
carnitine palmitoyltransferase 2 |
|
multiple interactions |
ISO |
5 |
129,007,685 |
129,025,501 |
RGD:6480464 |
CTD |
| G |
Cpt2 |
carnitine palmitoyltransferase 2 |
|
increases expression |
ISO |
5 |
129,007,685 |
129,025,501 |
RGD:6480464 |
CTD |
| G |
Crat |
carnitine O-acetyltransferase |
|
increases activity |
EXP |
3 |
9,447,585 |
9,461,180 |
RGD:6480464 |
CTD |
| G |
Crat |
carnitine O-acetyltransferase |
|
increases activity |
EXP |
3 |
9,447,585 |
9,461,180 |
RGD:6480464 |
CTD |
| G |
Crat |
carnitine O-acetyltransferase |
|
multiple interactions |
EXP |
3 |
9,447,585 |
9,461,180 |
RGD:6480464 |
CTD |
| G |
Crat |
carnitine O-acetyltransferase |
|
increases activity |
EXP |
3 |
9,447,585 |
9,461,180 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Crem |
cAMP responsive element modulator |
|
decreases expression |
ISO |
17 |
62,770,633 |
62,837,670 |
RGD:6480464 |
CTD |
| G |
Crot |
carnitine O-octanoyltransferase |
|
increases expression |
EXP |
4 |
22,023,913 |
22,067,029 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
decreases expression |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Cyb5r3 |
cytochrome b5 reductase 3 |
|
affects expression |
EXP |
7 |
121,187,821 |
121,205,382 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
multiple interactions |
ISO |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
decreases expression |
ISO |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
multiple interactions |
EXP |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
increases expression |
ISO |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
increases expression |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
increases expression |
EXP |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
increases expression |
ISO |
5 |
135,546,858 |
135,578,199 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
affects expression |
EXP |
5 |
135,917,327 |
135,934,636 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
decreases expression |
EXP |
4 |
26,752,677 |
26,771,131 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
decreases activity |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Dbi |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
affects expression |
EXP |
1 |
204,245,562 |
204,258,913 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
increases expression |
EXP |
6 |
134,022,016 |
134,043,058 |
RGD:6480464 |
CTD |
| G |
Dnajb6 |
DnaJ (Hsp40) homolog, subfamily B, member 6 |
|
decreases expression |
ISO |
4 |
732,491 |
796,237 |
RGD:6480464 |
CTD |
| G |
Dtnb |
dystrobrevin, beta |
|
decreases expression |
ISO |
6 |
26,542,148 |
26,742,199 |
RGD:6480464 |
CTD |
| G |
Ech1 |
enoyl CoA hydratase 1, peroxisomal |
|
increases expression |
ISO |
1 |
83,932,720 |
83,938,918 |
RGD:6480464 |
CTD |
| G |
Eci2 |
enoyl-CoA delta isomerase 2 |
|
increases expression |
EXP |
17 |
36,198,752 |
36,215,199 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
decreases expression |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
increases expression |
ISO |
11 |
81,474,161 |
81,507,645 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
increases expression |
ISO |
11 |
81,474,161 |
81,507,645 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
increases expression |
ISO |
11 |
81,474,161 |
81,507,645 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
multiple interactions |
ISO |
11 |
81,474,161 |
81,507,645 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
increases expression |
ISO |
11 |
81,474,161 |
81,507,645 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
multiple interactions |
ISO |
11 |
81,474,161 |
81,507,645 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
affects expression |
EXP |
11 |
81,474,161 |
81,507,645 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
increases expression |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
increases expression |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
multiple interactions |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
decreases expression |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
increases expression |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
increases expression |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
increases expression |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
multiple interactions |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
multiple interactions |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
increases expression |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
multiple interactions |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
increases expression |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp2 |
fatty acid binding protein 2, intestinal |
|
increases expression |
ISO |
2 |
219,591,502 |
219,605,097 |
RGD:6480464 |
CTD |
| G |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
|
decreases expression |
ISO |
5 |
149,340,525 |
149,347,268 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
EXP |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fads1 |
fatty acid desaturase 1 |
|
increases activity |
EXP |
1 |
212,670,792 |
212,685,718 |
RGD:6480464 |
CTD |
| G |
Fads1 |
fatty acid desaturase 1 |
|
increases activity |
EXP |
1 |
212,670,792 |
212,685,718 |
RGD:6480464 |
CTD |
| G |
Fads2 |
fatty acid desaturase 2 |
|
increases activity |
EXP |
1 |
212,512,691 |
212,542,622 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
affects expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
increases expression |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
multiple interactions |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
increases expression |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
multiple interactions |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
multiple interactions |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
increases expression |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
increases expression |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
increases expression |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
increases expression |
ISO |
1 |
96,082,475 |
96,083,718 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
multiple interactions |
ISO |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
multiple interactions |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
multiple interactions |
ISO |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
decreases expression |
ISO |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
increases expression |
ISO |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
|
increases expression |
ISO |
7 |
138,458,875 |
138,466,266 |
RGD:6480464 |
CTD |
| G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
|
multiple interactions |
ISO |
7 |
138,458,875 |
138,466,266 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Hadha |
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit |
|
increases expression |
ISO |
6 |
26,173,798 |
26,191,433 |
RGD:6480464 |
CTD |
| G |
Hadhb |
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit |
|
increases expression |
ISO |
6 |
26,139,397 |
26,173,428 |
RGD:6480464 |
CTD |
| G |
Hdac3 |
histone deacetylase 3 |
|
multiple interactions |
ISO |
18 |
30,857,209 |
30,875,986 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
decreases activity |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
increases activity |
ISO |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
decreases activity |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
increases expression |
ISO |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
multiple interactions |
ISO |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
increases expression |
ISO |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
decreases activity |
ISO |
13 |
109,063,491 |
109,089,468 |
RGD:6480464 |
CTD |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
decreases expression |
ISO |
13 |
109,063,491 |
109,089,468 |
RGD:6480464 |
CTD |
| G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
|
increases expression |
ISO |
18 |
45,157,435 |
45,251,606 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
EXP |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
decreases expression |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
increases expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
increases expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
increases expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
increases expression |
EXP |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases expression |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases expression |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
ISO |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lipc |
lipase, hepatic |
|
increases activity |
ISO |
8 |
75,323,442 |
75,450,353 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases activity |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases activity |
EXP |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
EXP |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
EXP |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases activity |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases activity |
EXP |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases activity |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Ly6d |
lymphocyte antigen 6 complex, locus D |
|
increases expression |
ISO |
7 |
112,872,991 |
112,874,499 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mgll |
monoglyceride lipase |
|
increases expression |
ISO |
4 |
122,822,493 |
122,922,892 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mpeg1 |
macrophage expressed 1 |
|
decreases expression |
ISO |
1 |
215,387,912 |
215,390,172 |
RGD:6480464 |
CTD |
| G |
Mpg |
N-methylpurine-DNA glycosylase |
|
increases expression |
ISO |
10 |
15,643,334 |
15,649,561 |
RGD:6480464 |
CTD |
| G |
Mttp |
microsomal triglyceride transfer protein |
|
increases expression |
ISO |
2 |
235,613,710 |
235,654,848 |
RGD:6480464 |
CTD |
| G |
Mttp |
microsomal triglyceride transfer protein |
|
decreases expression |
ISO |
2 |
235,613,710 |
235,654,848 |
RGD:6480464 |
CTD |
| G |
Mttp |
microsomal triglyceride transfer protein |
|
multiple interactions |
ISO |
2 |
235,613,710 |
235,654,848 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
6 |
27,224,396 |
27,473,926 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
5 |
5,197,891 |
5,275,776 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases phosphorylation |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
increases expression |
ISO |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
multiple interactions |
EXP |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
multiple interactions |
ISO |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
increases expression |
ISO |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
increases stability |
ISO |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
increases expression |
ISO |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
increases expression |
ISO |
5 |
151,524,685 |
151,528,000 |
RGD:6480464 |
CTD |
| G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
multiple interactions |
ISO |
5 |
151,524,685 |
151,528,000 |
RGD:6480464 |
CTD |
| G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
increases expression |
ISO |
1 |
95,027,197 |
95,032,516 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
multiple interactions |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
increases expression |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
affects response to substance |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
multiple interactions |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
affects response to substance |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
increases expression |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
multiple interactions |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
increases expression |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
increases expression |
ISO |
7 |
26,189,759 |
26,307,061 |
RGD:6480464 |
CTD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
increases expression |
ISO |
7 |
26,189,759 |
26,307,061 |
RGD:6480464 |
CTD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
multiple interactions |
ISO |
7 |
26,189,759 |
26,307,061 |
RGD:6480464 |
CTD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
increases expression |
ISO |
7 |
26,189,759 |
26,307,061 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases expression |
EXP |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nthl1 |
nth (endonuclease III)-like 1 (E.coli) |
|
increases expression |
ISO |
10 |
13,883,284 |
13,889,790 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
increases expression |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Pc |
pyruvate carboxylase |
|
increases expression |
EXP |
1 |
207,112,853 |
207,212,737 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
decreases expression |
ISO |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcsk9 |
proprotein convertase subtilisin/kexin type 9 |
|
increases expression |
ISO |
5 |
127,501,476 |
127,524,289 |
RGD:6480464 |
CTD |
| G |
Pdha1 |
pyruvate dehydrogenase (lipoamide) alpha 1 |
|
increases expression |
EXP |
X |
55,899,491 |
55,913,319 |
RGD:6480464 |
CTD |
| G |
Pdk2 |
pyruvate dehydrogenase kinase, isozyme 2 |
|
increases expression |
ISO |
10 |
83,710,448 |
83,724,973 |
RGD:6480464 |
CTD |
| G |
Pdk2 |
pyruvate dehydrogenase kinase, isozyme 2 |
|
multiple interactions |
ISO |
10 |
83,710,448 |
83,724,973 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
increases expression |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
increases expression |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
increases expression |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
increases expression |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
multiple interactions |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
increases expression |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
multiple interactions |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
decreases activity |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
multiple interactions |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Pnliprp2 |
pancreatic lipase-related protein 2 |
|
increases expression |
ISO |
1 |
265,267,609 |
265,285,920 |
RGD:6480464 |
CTD |
| G |
Polr2a |
polymerase (RNA) II (DNA directed) polypeptide A |
|
multiple interactions |
ISO |
10 |
56,552,872 |
56,579,172 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
decreases expression |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases activity |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
decreases expression |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
affects binding |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases response to substance |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
affects binding |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
affects binding |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
affects response to substance |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
affects response to substance |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
affects binding |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
multiple interactions |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
affects binding |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases expression |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
affects binding |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
multiple interactions |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases activity |
EXP |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases expression |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
affects binding |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases expression |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
decreases expression |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases expression |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
affects binding |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases expression |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
multiple interactions |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases expression |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases expression |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
affects binding |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Psmc3ip |
PSMC3 interacting protein |
|
decreases expression |
ISO |
10 |
90,108,909 |
90,112,013 |
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
increases expression |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Rmnd1 |
required for meiotic nuclear division 1 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
35,114,371 |
35,132,050 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
increases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
multiple interactions |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Scap |
SREBF chaperone |
|
decreases expression |
ISO |
8 |
114,706,479 |
114,761,342 |
RGD:6480464 |
CTD |
| G |
Scap |
SREBF chaperone |
|
increases expression |
ISO |
8 |
114,706,479 |
114,761,342 |
RGD:6480464 |
CTD |
| G |
Scap |
SREBF chaperone |
|
multiple interactions |
ISO |
8 |
114,706,479 |
114,761,342 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
increases activity |
EXP |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
increases expression |
ISO |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
decreases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
multiple interactions |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases activity |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Sele |
selectin E |
|
multiple interactions |
ISO |
13 |
79,813,455 |
79,822,845 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases activity |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases secretion |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
multiple interactions |
ISO |
16 |
18,769,909 |
18,786,988 |
RGD:6480464 |
CTD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
increases expression |
ISO |
16 |
18,769,909 |
18,786,988 |
RGD:6480464 |
CTD |
| G |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
|
multiple interactions |
ISO |
3 |
114,072,570 |
114,114,269 |
RGD:6480464 |
CTD |
| G |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
|
increases expression |
ISO |
3 |
114,072,570 |
114,114,269 |
RGD:6480464 |
CTD |
| G |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
|
multiple interactions |
ISO |
3 |
114,072,570 |
114,114,269 |
RGD:6480464 |
CTD |
| G |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
|
increases expression |
ISO |
3 |
114,072,570 |
114,114,269 |
RGD:6480464 |
CTD |
| G |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
|
increases expression |
ISO |
3 |
114,072,570 |
114,114,269 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
multiple interactions |
ISO |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
decreases expression |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
multiple interactions |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Smpd1 |
sphingomyelin phosphodiesterase 1, acid lysosomal |
|
increases activity |
EXP |
1 |
163,278,970 |
163,282,813 |
RGD:6480464 |
CTD |
| G |
Smpd2 |
sphingomyelin phosphodiesterase 2, neutral membrane |
|
multiple interactions |
EXP |
20 |
45,448,774 |
45,451,887 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
decreases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
|
increases expression |
ISO |
7 |
120,522,511 |
120,580,212 |
RGD:6480464 |
CTD |
| G |
Suclg1 |
succinate-CoA ligase, alpha subunit |
|
increases expression |
EXP |
4 |
106,572,140 |
106,601,495 |
RGD:6480464 |
CTD |
| G |
Tdg |
thymine-DNA glycosylase |
|
increases expression |
ISO |
7 |
23,300,450 |
23,320,095 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
decreases expression |
EXP |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
decreases expression |
EXP |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
decreases expression |
EXP |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases response to substance |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases response to substance |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
multiple interactions |
ISO |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
increases expression |
ISO |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
multiple interactions |
EXP |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
increases expression |
EXP |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
affects expression |
EXP |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
multiple interactions |
EXP |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
increases expression |
EXP |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
increases expression |
ISO |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
increases expression |
ISO |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
increases expression |
EXP |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
decreases expression |
EXP |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
increases expression |
ISO |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
increases expression |
EXP |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
increases expression |
ISO |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
increases expression |
ISO |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcan |
versican |
|
decreases expression |
ISO |
2 |
19,712,629 |
19,801,443 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
multiple interactions |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
decreases activity |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
decreases expression |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Zfp704 |
zinc finger protein 704 |
|
increases expression |
ISO |
2 |
94,202,644 |
94,394,132 |
RGD:6480464 |
CTD |
Term paths to the root
|